Additionally, they could demonstrate that a higher percentage of LAG-3+ cells was associated with poor differentiation, lymph node metastasis and invasion [26], whereas no correlation of LAG-3 expression with any of the clinicopathological characteristics such as tumor grade, vascular invasion or tumor budding could be observed in our study cohort of stage II colon cancer. This evidence concerns the gene LAG3 and neoplasm.